Xiaobei Hu
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 13
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 6
- DNA Repair Mechanisms 3
- Cancer therapeutics and mechanisms 2
- Oncology 9
- Peptidase Inhibition and Analysis 4
- Co-authors
- Yubo Zhou (20 shared papers)Jia Li (17 shared papers)Jia Li (2 shared papers)Lei Xu (6 shared papers)Lina Zhang (1 shared paper)Haowen Jiang (1 shared paper)Mingfeng Xia (1 shared paper)Lingyan Wu (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (9 papers)European Journal of Medicinal Chemistry (8 papers)Acta Pharmacologica Sinica (2 papers)Current Medical Research and Opinion (1 paper)Cancer Letters (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xiaobei Hu
26 papers receiving 472 citations
Peers
Comparison fields: 5 of 65
- Hematology 83
- Oncology 132
- Molecular Biology 282
- Geriatrics and Gerontology 12
- Genetics 31
Countries citing papers authored by Xiaobei Hu
This map shows the geographic impact of Xiaobei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobei Hu more than expected).
Fields of papers citing papers by Xiaobei Hu
This network shows the impact of papers produced by Xiaobei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobei Hu. The network helps show where Xiaobei Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 112 | |
| 2 | 2021 | 61 | |
| 3 | 2015 | 34 | |
| 4 | 2019 | 23 | |
| 5 | 2021 | 20 | |
| 6 | 2019 | 20 | |
| 7 | 2021 | 20 | |
| 8 | 2019 | 19 | |
| 9 | 2022 | 18 | |
| 10 | 2018 | 16 | |
| 11 | 2022 | 15 | |
| 12 | 2024 | 12 | |
| 13 | 2021 | 12 | |
| 14 | 2016 | 11 | |
| 15 | 2023 | 11 | |
| 16 | 2020 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2015 | 8 |
About Xiaobei Hu
Xiaobei Hu is a scholar working on Molecular Biology, Oncology, Hematology, Cell Biology and Genetics, having authored 26 papers that have together received 477 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Peptidase Inhibition and Analysis (4 papers), DNA Repair Mechanisms (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (83 citations), Oncology (132 citations), Molecular Biology (282 citations), Geriatrics and Gerontology (12 citations) and Genetics (31 citations). Xiaobei Hu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yubo Zhou, Jia Li, Jia Li, Lei Xu, Lina Zhang, Haowen Jiang, Mingfeng Xia, Lingyan Wu, Yanan Duan and Yiqiu Zhang. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Current Medical Research and Opinion and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.